Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1846 AL 1860

Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions

Sawicka-Gutaj N, Zawalna N, Gut P, Ruchała M.

Pharmacol Rep. 2022 Oct;74(5):847-858. doi: 10.1007/s43440-022-00377-w. Epub 2022 Jun 30.

Editorial: Neurodegeneration: From Disease Mechanism to Therapeutic Advancement

Sarkar PS, Meola G, Zhang N.

Front Genet. 2022 Jun 14;13:941846. doi: 10.3389/fgene.2022.941846. eCollection 2022.

A novel mechanism of sudden infant death syndrome during atrioventricular reentrant tachycardia: a case report

Mori H, Sumitomo N, Tsutsui K, Nabeshima T.

Eur Heart J Case Rep. 2022 Jun 16;6(6):ytac240. doi: 10.1093/ehjcr/ytac240. eCollection 2022 Jun.

COVID-19 and neurodegenerative diseases

Fu YW, Xu HS, Liu SJ.

Eur Rev Med Pharmacol Sci. 2022 Jun;26(12):4535-4544. doi: 10.26355/eurrev_202206_29093.

The Influence of Wearables on Health Care Outcomes in Chronic Disease: Systematic Review

Mattison G, Canfell O, Forrester D, Dobbins C, Smith D, Töyräs J, Sullivan C.

J Med Internet Res. 2022 Jul 1;24(7):e36690. doi: 10.2196/36690.

Psychological outcomes of the COVID-19 pandemic in patients with Parkinson's disease: A systematic review

Nabizadeh F, Seyedalhosseini Z, Balabandian M, Reza Rostami M.

J Clin Neurosci. 2022 Aug;102:101-108. doi: 10.1016/j.jocn.2022.06.017. Epub 2022 Jun 28.

(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression

Wang X, Yang J, Hashimoto K.

Neurosci Biobehav Rev. 2022 Aug;139:104762. doi: 10.1016/j.neubiorev.2022.104762. Epub 2022 Jun 30.

The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases

Tsafaras G, Baekelandt V.

Neurobiol Dis. 2022 Oct 1;172:105806. doi: 10.1016/j.nbd.2022.105806. Epub 2022 Jun 30.

Systematic review of data-driven cognitive subtypes in Parkinson disease

Pourzinal D, Yang J, Lawson RA, McMahon KL, Byrne GJ, Dissanayaka NN.

Eur J Neurol. 2022 Nov;29(11):3395-3417. doi: 10.1111/ene.15481. Epub 2022 Jul 18.

Regulation of Oxidative Stress by Long Non-coding RNAs in Central Nervous System Disorders

Xu X, Zhang Y.

Front Mol Neurosci. 2022 Jun 15;15:931704. doi: 10.3389/fnmol.2022.931704. eCollection 2022.

Application of Metal-Based Nanozymes in Inflammatory Disease: A Review

Li R, Hou X, Li L, Guo J, Jiang W, Shang W.

Front Bioeng Biotechnol. 2022 Jun 16;10:920213. doi: 10.3389/fbioe.2022.920213. eCollection 2022.

Neuroprotective effects of carvacrol against Alzheimer's disease and other neurodegenerative diseases: A review

Azizi Z, Majlessi N, Choopani S, Naghdi N.

Avicenna J Phytomed. 2022 Jul-Aug;12(4):371-387. doi: 10.22038/AJP.2022.19491.

Metabolic Mechanisms Connecting Alzheimer's and Parkinson's Diseases: Potential Avenues for Novel Therapeutic Approaches

Colca JR, Finck BN.

Front Mol Biosci. 2022 Jun 16;9:929328. doi: 10.3389/fmolb.2022.929328. eCollection 2022.

R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy

Cuartas J, Gangwani L.

Front Cell Neurosci. 2022 Jun 16;16:826608. doi: 10.3389/fncel.2022.826608. eCollection 2022.

Prionoids in amyotrophic lateral sclerosis

Gosset P, Camu W, Raoul C, Mezghrani A.

Brain Commun. 2022 Jun 9;4(3):fcac145. doi: 10.1093/braincomms/fcac145. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias